GLP-1 medications used for diabetes and weight loss may do more than help control blood sugar and appetite. A new study ...
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to ...
ScienceAlert on MSN
Weight loss on GLP-1 drugs linked to lower risk of disease, study finds
(Viktoriya Skorikova/Moment/Getty Images) Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually ...
New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...
GLP-1 medications have become a go-to for managing type 2 diabetes and supporting weight loss, offering benefits like ...
GLP-1 medications like Ozempic and Wegovy are used for weight loss and diabetes. Learn how they work, their costs, and potential side effects.
The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as ...
Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with type 2 diabetes.
Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need to know before July 2026.
HealthDay on MSN
GLP-1 drugs linked to better breast cancer outcomes
Popular GLP-1 medications may be linked to better long-term outcomes for some breast cancer patients. Previous research has shown breast cancer survivors with obesity or type 2 diabetes often ...
Among patients with obesity, GLP-1 RAs were associated with a lower hazard of all-cause mortality and recurrence-free survival over a 10-year follow-up period. (HealthDay News) — Glucagon-like peptide ...
Editor's note: All opinions, columns and letters reflect the views of the individual writer and not necessarily those of the IDS or its staffers. Insulin should have belonged to the world; the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results